LOTM: ARK Genomic & BEAM Therapeutics – Technical Comments

Chart, histogram

Description automatically generated

Beam (BEAM)* is the leading performer in the Genetic / BioScience sector. Since June 13th Bean has moved from $28 to its current price of $52 per share. Beam in our opinion has great potential but is still a story stock until revenue is flowing – which it is not now. This move is strictly technical in nature IMO. At this stage we’d be a bit careful and treat Beam as a trading number and work it technically only. You can check the fundamental stats page linked here.

It appears Beam (genomic stocks) could be a “risk on trade” as anticipation is building that the commodity price collapse will cause the Fed to at pause its interest rate hikes following the anticipated July hike.

The sharp drop in commodity prices “should” allow the inflation numbers to drop in August and September. I expect Nat Gas to be a very strong performer this winter as shortages could appear during the winter heating season. Buy your Nat Gas stocks this summer on the Nat Gas price weakness as a side comment.

Look for a few more days of weakness in Beam towards the $46 – $48 level for a trade. It could retreat and test as low as the 45-day moving average around $38, but you might start staging in for a trade with another 5% to 7% retreat from the current price of $51.

While Beam is the performance leader of the genomic pack of companies, ARK Genomics (ARKG) ETF is a secondary and less volatile way to play the group. I would call on ARKG as a way to get exposure to the sector for a longer-term play in the industry. I am still leaning into expecting more rate hikes after the November elections. Therefore, the Genomics group is a trade for me at this time. One can never say for sure, however.

Six month daily Chart:

Chart, histogram

Description automatically generated

Two year weekly chart:

Chart

It is always goo to see the perspective of short and long term patterns even it short-term trading. A 5% correction in ARKG is about right for an initial trade position. NOTE: I always like to make three purchases even when day-trading to average out my cost. My stop loss price is then based on the average cost of the three purchases. This is a probabilities game so anything you can do to increase your probability of success helps. Guessing is not as productive or consistent as a disciplined strategy. The market is more random than a disciplined strategy so consider that you have to be the constant in the randomness of market action.

That’s about it. Trading suggestions as long as we have a risk on market.

Have a great day! Tom.

Written by Tom Linzmeier @ #LivingOffTheMarket.com on July 11, 2022.

Keywords: #stocks #genomicstocks #biotech #bioscience #riskonstocks #growthstocks #marketstrategy

LOTM Research & Consulting Service
* An account related to LOTM holds a position in this security.
Neither LOTM nor Tom Linzmeier is a Registered Investment Advisor.
Please refer to our web site for full disclosure at www.LivingOffTheMarket.com ZTA Capital Group, Inc.
To Unsubscribe please select “return” and type Unsubscribe in the subject line.

Loading

This entry was posted in Tom's Blog. Bookmark the permalink.